M-cap of BSE-listed firms is just 2000 pts away from its all-time high
Thu, Aug 18, 2022 9:21 PM

M-cap of BSE-listed firms is just 2000 pts away from its all-time high

A Flip by Farha
Get it on Google Play
On Thursday, the market capitalisation of the BSE-listed companies reached an all time high of more than ₹280.52 lakh crore on Thursday, helped by the recent rally in equities. The benchmark marked its fifth straight session of gains with this hike today. The 30-share BSE Sensex today ended 37.87 points or 0.06 per cent higher at 60,298. From its all time highs, Sensex is now 2,000 points away.

More great flips

Gifty Nifty rises 30 points; here's the trading setup for today's session!

Gifty Nifty rises 30 points; here's the trading setup for today's session!

Equity markets continued their winning streak for the sixth consecutive day on Tuesday. Analysts said the global and domestic markets made a smart comeback as investors remained convinced that the rate-hike cycle has ended. Going forward, investors will take cues from US Service PMI and Jolt Jobs data, said Siddhartha Khemka, Head - Retail Research, Motilal Oswal.

Open Flip
Eicher faces a Himalayan challenge in H2; Hero MotoCorp, Bajaj Auto!

Eicher faces a Himalayan challenge in H2; Hero MotoCorp, Bajaj Auto!

Eicher Motors has long been synonymous with the premium motorcycle segment in India, maintaining a market share of about 90 percent. It has held an undisputed leadership position in the over 250cc sector for more than a decade. However, this dominance is currently facing a potential challenge as two established players seek to make inroads into the market.

Open Flip
Sun Pharma subsidiary seals licensing agreement with Aclaris Therapeutics!

Sun Pharma subsidiary seals licensing agreement with Aclaris Therapeutics!

Sun Pharmaceutical Industries, Inc., on December 6, announced that it has entered into a licensing agreement with Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company specialising in the development of innovative drugs for immuno-inflammatory diseases. Under the terms of the agreement, Aclaris has exclusively granted Sun Pharma the rights to specific patents.

Open Flip

Join our Smart Investment Community

More than 1 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon